BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 25449711)

  • 1. GABAergic mechanisms of hippocampal hyperactivity in schizophrenia.
    Heckers S; Konradi C
    Schizophr Res; 2015 Sep; 167(1-3):4-11. PubMed ID: 25449711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal neurons in schizophrenia.
    Heckers S; Konradi C
    J Neural Transm (Vienna); 2002 May; 109(5-6):891-905. PubMed ID: 12111476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism.
    Braun I; Genius J; Grunze H; Bender A; Möller HJ; Rujescu D
    Schizophr Res; 2007 Dec; 97(1-3):254-63. PubMed ID: 17601703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parvalbumin and GAD65 interneuron inhibition in the ventral hippocampus induces distinct behavioral deficits relevant to schizophrenia.
    Nguyen R; Morrissey MD; Mahadevan V; Cajanding JD; Woodin MA; Yeomans JS; Takehara-Nishiuchi K; Kim JC
    J Neurosci; 2014 Nov; 34(45):14948-60. PubMed ID: 25378161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABA abnormalities in schizophrenia: a methodological review of in vivo studies.
    Taylor SF; Tso IF
    Schizophr Res; 2015 Sep; 167(1-3):84-90. PubMed ID: 25458856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia.
    Lin H; Hsu FC; Baumann BH; Coulter DA; Anderson SA; Lynch DR
    Mol Cell Neurosci; 2014 Jul; 61():163-75. PubMed ID: 24983521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and glucose metabolism: potential roles in GABAergic interneuron pathology.
    Schubert KO; Föcking M; Cotter DR
    Schizophr Res; 2015 Sep; 167(1-3):64-72. PubMed ID: 25728835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Development of Parvalbumin-, Somatostatin-, and Cholecystokinin-Expressing Neurons in Rat Brain following Prenatal Immune Activation and Maternal Iron Deficiency.
    Boksa P; Zhang Y; Nouel D; Wong A; Wong TP
    Dev Neurosci; 2016; 38(5):342-353. PubMed ID: 28214898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The maternal immune activation model uncovers a role for the Arx gene in GABAergic dysfunction in schizophrenia.
    Nakamura JP; Schroeder A; Hudson M; Jones N; Gillespie B; Du X; Notaras M; Swaminathan V; Reay WR; Atkins JR; Green MJ; Carr VJ; Cairns MJ; Sundram S; Hill RA
    Brain Behav Immun; 2019 Oct; 81():161-171. PubMed ID: 31175998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amygdalar activation alters the hippocampal GABA system: "partial" modelling for postmortem changes in schizophrenia.
    Berretta S; Munno DW; Benes FM
    J Comp Neurol; 2001 Mar; 431(2):129-38. PubMed ID: 11169995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GABA-glutamate connection in schizophrenia: which is the proximate cause?
    Coyle JT
    Biochem Pharmacol; 2004 Oct; 68(8):1507-14. PubMed ID: 15451393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium binding protein markers of GABA deficits in schizophrenia--postmortem studies and animal models.
    Reynolds GP; Abdul-Monim Z; Neill JC; Zhang ZJ
    Neurotox Res; 2004; 6(1):57-61. PubMed ID: 15184106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rodent model of schizophrenia derived from postmortem studies.
    Berretta S; Gisabella B; Benes FM
    Behav Brain Res; 2009 Dec; 204(2):363-8. PubMed ID: 19539659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interneuron precursor transplants in adult hippocampus reverse psychosis-relevant features in a mouse model of hippocampal disinhibition.
    Gilani AI; Chohan MO; Inan M; Schobel SA; Chaudhury NH; Paskewitz S; Chuhma N; Glickstein S; Merker RJ; Xu Q; Small SA; Anderson SA; Ross ME; Moore H
    Proc Natl Acad Sci U S A; 2014 May; 111(20):7450-5. PubMed ID: 24794528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia.
    Osborne AL; Solowij N; Babic I; Lum JS; Newell KA; Huang XF; Weston-Green K
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109666. PubMed ID: 31202911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interneuron NMDA Receptor Ablation Induces Hippocampus-Prefrontal Cortex Functional Hypoconnectivity after Adolescence in a Mouse Model of Schizophrenia.
    Alvarez RJ; Pafundo DE; Zold CL; Belforte JE
    J Neurosci; 2020 Apr; 40(16):3304-3317. PubMed ID: 32205341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha7 nicotinic acetylcholine receptors on GABAergic interneurons evoke dendritic and somatic inhibition of hippocampal neurons.
    Buhler AV; Dunwiddie TV
    J Neurophysiol; 2002 Jan; 87(1):548-57. PubMed ID: 11784770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis.
    Modinos G; Şimşek F; Azis M; Bossong M; Bonoldi I; Samson C; Quinn B; Perez J; Broome MR; Zelaya F; Lythgoe DJ; Howes OD; Stone JM; Grace AA; Allen P; McGuire P
    Neuropsychopharmacology; 2018 Dec; 43(13):2652-2659. PubMed ID: 29440719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene.
    Kimoto S; Zaki MM; Bazmi HH; Lewis DA
    JAMA Psychiatry; 2015 Aug; 72(8):747-56. PubMed ID: 26038830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats.
    Abekawa T; Ito K; Nakagawa S; Koyama T
    Psychopharmacology (Berl); 2007 Jun; 192(3):303-16. PubMed ID: 17340116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.